Analysis of prognostic factors in male breast cancer: A report of 72 cases from a single institution

Chinese Journal of Cancer

Volumn 29, Issue 2, 2010, Pages 184-188

  Zhou, Fei Fei ^a   Xia, Liang Ping ^a   Wang, Xi ^a   Guo, Gui Fang ^a   Rong, Yu Ming ^a   Qiu, Hui Juan ^a   Zhang, Bei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Male breast cancer; Multlvarlate; Prognosls; Survlval rate; Unlvarlate

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TEGAFUR; THIOTEPA;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISTANT METASTASIS; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

EID: 78649883022     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10499     Document Type: Article

References (22)

1. Contractor KB, Kaur K, Rodrigues GS, et al. Male breast cancer: is the scenario changing [J]. World J Surg Oncol, 2008,6(58):1-11.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006 [J]. CA Cancer J Clin, 2006,56(2):106-130.
3. Speirs V, Shaaban AM. The rising incidence of male breast cancer [J]. Breast Cancer Res Treat, 2009,115(2):429-430.
4. Liang CM, Wang J, Wang P. Clinical analysis of 30 cases of male breast cancer [J]. Chin J Breast Dis, 2008,2(5):18-21. [in Chinese]
5. Shang JQ, Zhao XS, Zhou JN. Treatment and prognosis of male breast cancer [J]. Chin J Cancer, 1999,18(2):227-228. [in Chinese]
6. Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men [J]. Cancer, 2004,101(1):51-57.
7. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996 [J]. Cancer, 1999,85(3):629-639.
8. Cutuli B, Le-Nir CC, Serin D, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases [J]. Crit Rev Oncol Hematol, 2009, 11. [Epub ahead of print]
9. Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlightsof the international expert consensus on the primary therapy of early breast cancer 2007 [J]. Ann Oncol, 2007,18(7):1133-1144.
10. Yildirim E, Berberoglu U. Male breast cancer: a 22-ye ar experience [J]. Eur J Surg Oncol, 1998,24(6):548-552.
11. Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast [J]. Am J Clin Oncol, 1987,10(1):55-60.
12. Walshe JM, Berman AW, Vatas U, et al. A prospective study of adjuvant CMF in male with node positive breast cancer 20-ye ar follow-up [J]. Breast Cancer Res Treat, 2007,103(2):177-183.
13. Chakravarthy A, Kim CR. Post-m astectomy radiation in male breast cancer [J]. Radiother Oncol, 2002,65(2):99-103.
14. Zabel A, Milker-Za bel S, Zuna I, et al. External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience [J]. Tumori, 2005,91(2):151-155.
15. Yoney A, Kucuk A, Unsal M. Male breast cancer: a retrospective analysis [J]. Cancer Radiother, 2009,13(2):103-107.
16. Ottini L, Palli D, Rizzoc S, et al. Male breast cancer [J]. Crit Rev Oncol Hematol, 2009, 6. [Epub ahead of print]
17. Tarone RE, Chu KC. The greater impact of menopause on ER than ER+ breast cancer incidence: a possible explanation (United States) [J]. Cancer Causes Control, 2002,13(1):7-14.
18. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers: a population-ba sed comparative immunohistochemical analysis [J]. Arch Pathol Lab Med, 2003,127(1):36-41.
19. Avisar E, McParland E, Dicostanzo D, et al. Prognostic factors in node- negative male breast cancer [J]. Clin Breast Cancer, 2006,7(4):331-335.
20. Iredale R, Brain K, Williams B, et al. The experiences of men with breast cancer in the United Kingdom [J] Eur J Cancer, 2006, 42(3):334-341.
21. Mauras N, Brien KO, Klein KO, et al. Estrogen suppression in males: metabolic effects [J]. J Clin Endocrinol Metab, 2000,85(7):2370-2377.
22. Zabolotny BP, Zalai CV, Meterissian SH. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer [J]. J Surg Oncol, 2005,90(1):26-30.